Results 111 to 120 of about 23,233 (232)

Extracavitary tumor after primary effusion lymphoma: relapse or second distinct lymphoma?

open access: yesHaematologica, 2007
HHV-8-associated solid lymphomas which develop in extracavitary sites during the course of primary effusion lymphoma (PEL) could represent the relapse of original PEL tumors in different anatomical sites, or newly occurring distinct HHV-8-associated ...
Emmanuelle Boulanger   +6 more
doaj   +1 more source

Correlazione tra genotipo di HHV-8 e carica virale [PDF]

open access: yes
Il virus erpetico umano 8 (HHV8) o erpesvirus umano associato al sarcoma di Kaposi (KSHV) è l’agente eziologico del sarcoma di Kaposi (KS), una neoplasia angioproliferativa e di due rari disordini linfoproliferativi: il linfoma ad effusione primaria (PEL/
IMPEDUGLIA, VIVIANA
core  

Prevalence of Kaposi’s sarcoma-associated herpesvirus in Uygur and Han populations from the Urumqi and Kashgar regions of Xinjiang, China [PDF]

open access: yes, 2017
Kaposi’s sarcoma-associated herpesvirus (KSHV) is the infectious etiologic agent associated with Kaposi’s sarcoma (KS), primary effusion lymphoma, and multicentric Castleman disease.
Cui, Meng   +8 more
core   +1 more source

β-HHVs and HHV-8 in Lymphoproliferative Disorders.

open access: yesMediterranean journal of hematology and infectious diseases, 2011
Similarly to Epstein-Barr virus (EBV), the human herpesvirus-8 (HHV-8) is a γ-herpesvirus, recently recognized to be associated with the occurrence of rare B cell lymphomas and atypical lymphoproliferations, especially in the human immunodeficiency virus (HIV) infected subjects. Moreover, the human herpesvirus-6 (HHV-6), a β-herpesvirus, has been shown
QUADRELLI, Chiara   +7 more
openaire   +2 more sources

Remembering the forgotten child: the role of immune checkpoint inhibition in patients with human immunod eficiency virus and cancer. [PDF]

open access: yes, 2019
Patients with human immunodeficiency virus (HIV) infection have a high risk of developing virally-mediated cancers. These tumors have several features that could make them vulnerable to immune checkpoint inhibitors (ICIs) including, but not limited to ...
Adashek, Jacob J   +3 more
core  

Human Herpesvirus 8 (HHV-8) Staining: A Savior in Early Kaposi Sarcoma. [PDF]

open access: yesCureus, 2023
Siddiqui F   +4 more
europepmc   +1 more source

No Evidence of Human Herpesvirus 8 among Iranian Patients Infected with HIV

open access: yesIranian Journal of Public Health, 2016
Background: Kaposi’s sarcoma is a vascular malignancy, which frequently occurs among immunocompromised individuals such as transplant recipients and patients with acquired immunodeficiency syndrome.
Amitis RAMEZANI   +8 more
doaj  

Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report. [PDF]

open access: yesMedicina (Kaunas), 2023
Caballero JC   +10 more
europepmc   +1 more source

Serological study of the frequency of human herpesvirus-8 in patients with liver cirrhosis [PDF]

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām
Introduction:  Various factors, including viruses, are involved in developing liver cirrhosis. Although the association of human herpesvirus-8 (HHV-8) with liver cirrhosis remains poorly understood, a significant increase in the titer of antibodies ...
Ava Hashempour   +2 more
doaj  

First survey for detecting the presence of human herpesvirus 8 infection (HHV-8) in Maputo, Mozambique

open access: yesBrazilian Journal of Infectious Diseases
Human herpesvirus 8 (HHV-8), the etiological agent of Kaposi's sarcoma (KS), is endemic in parts of the sub-Saharan, and KS has increased concomitantly with the HIV/AIDS epidemic. In Mozambique (MZ), no data concerning HHV-8 infection was available, thus
Adele Caterino-de-Araujo   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy